(Q41435348)

30 September 2017

1 reference

title

Selective serotonin reuptake inhibitors in older patients. A tolerability perspective (English)

1 reference

30 September 2017

Skerritt U

1

1 reference

30 September 2017

Evans R

series ordinal

2

1 reference

30 September 2017

Montgomery SA

series ordinal

3

1 reference

30 September 2017

publication date

1 March 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

10

1 reference

30 September 2017

issue

3

1 reference

30 September 2017

page(s)

209-218

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199710030-00005

30 September 2017

exact match

0 references

cites work

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

1 reference

12 December 2020

Effect of fluoxetine on the electrocardiogram.

1 reference

12 December 2020

A double-blind, randomised comparison of fluvoxamine with dothiepin in the treatment of depression in elderly patients

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

1 reference

12 December 2020

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

1 reference

12 December 2020

Drug treatment as a cause of falls in old age. A review of the offending agents

1 reference

12 December 2020

Depression increases mortality and morbidity in acute life-threatening medical illness

1 reference

12 December 2020

The advantages of paroxetine in different subgroups of depression

1 reference

12 December 2020

Psychotropic drugs and injuries among the elderly: a review

1 reference

12 December 2020

Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients

1 reference

12 December 2020

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

12 December 2020

Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people

1 reference

12 December 2020

The safety of fluoxetine--an update

1 reference

12 December 2020

Kinetics of citalopram in elderly patients

1 reference

12 December 2020

Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine

1 reference

12 December 2020

Fluoxetine-induced bradycardia and syncope in two patients

1 reference

12 December 2020

Unexpected deaths in depressed medical inpatients treated with fluoxetine

1 reference

12 December 2020

Dysrhythmia associated with fluoxetine treatment in an elderly patient with cardiac disease

1 reference

12 December 2020

The prognosis of depression in old age

1 reference

12 December 2020

Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.

1 reference

12 December 2020

The diagnosis of depression in the elderly

1 reference

12 December 2020

Fluoxetine-induced sexual dysfunction

1 reference

12 December 2020

Fluoxetine Versus Trazodone in Depressed Geriatric Patients

1 reference

12 December 2020

The optimal dosing regimen for citalopram--a meta-analysis of nine placebo-controlled studies

1 reference

12 December 2020

Fluoxetine disposition and elimination in cirrhosis

1 reference

12 December 2020

Adverse effects of antidepressants in the elderly

1 reference

12 December 2020

Depression: treatment compliance in general practice.

1 reference

12 December 2020

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

1 reference

12 December 2020

Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitryptiline

1 reference

12 December 2020

Clinical pharmacokinetics of citalopram and other selective serotonergic reuptake inhibitors (SSRI)

1 reference

12 December 2020

The Guy's/Age Concern survey. Prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community

1 reference

12 December 2020

The prognosis of depression in the elderly

1 reference

12 December 2020

The efficacy of fluoxetine as an antidepressant in the short and long term

1 reference

12 December 2020

Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.

1 reference

12 December 2020

Review of fluvoxamine safety database

1 reference

12 December 2020

The prognosis of depression in old age

1 reference

12 December 2020

Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy

1 reference

12 December 2020

A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression.

1 reference

12 December 2020

Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder

1 reference

12 December 2020

Pharmacologic treatment of depression in the elderly.

1 reference

12 December 2020

Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

The electrocardiogram as a tool for therapeutic monitoring: a critical analysis

1 reference

12 December 2020

Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo

1 reference

12 December 2020

Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression.

1 reference

12 December 2020

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

1 reference

12 December 2020

Serotonin nerve endings and regulation of pupillary diameter

1 reference

12 December 2020

Cognitive performance in geriatric subjects after acute treatment with antidepressants.

1 reference

12 December 2020

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

1 reference

12 December 2020

A pharmacokinetic dose titration study in adult and elderly depressed patients

1 reference

12 December 2020

Sleep and paroxetine: a comparison with mianserin in elderly depressed patients

1 reference

12 December 2020

Suicide and aging. I: Patterns of psychiatric diagnosis.

1 reference

12 December 2020

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

Antidepressants: the implications of the cognitive and psychomotor effects in the elderly

1 reference

12 December 2020

Tricyclic antidepressants in depressed patients with cardiac conduction disease

1 reference

12 December 2020

Depression and failure to resume social activities after stroke.

1 reference

12 December 2020

Fluoxetine: clinical pharmacology and physiologic disposition

1 reference

12 December 2020

Relative mortality from overdose of antidepressants

1 reference

12 December 2020

Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression

1 reference

12 December 2020

Paroxetine: an overview of dosage, tolerability, and safety

1 reference

12 December 2020

Sertraline-phenelzine drug interaction: a serotonin syndrome reaction

1 reference

12 December 2020

10.2165/00002512-199710030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

1051149779

0 references

1 reference